FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/091825 [Registered on: 28/07/2025] Trial Registered Prospectively
Last Modified On: 26/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Diagnostic 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Effect Of Erand Taila Yonipichu In Chronic Pelvic Inflammatory Disease. 
Scientific Title of Study   RANDOMIZED CONTROLLED CLINICAL TRIAL OF ERAND TAILA YONIPICHU IN THE MANAGEMENT OF PARIPLUTA YONIVYAPAD WITH SPECIAL REFERENCE TO CHRONIC PELVIC INFLAMMATORY DISEASE. 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DrPallavi Dinkar Kamthe  
Designation  PG Scholar  
Affiliation  LRP Ayurvedic Medical College and Hospital PG Institute and Research Centre Urun Islampur  
Address  LRP Ayurvedic Medical College and Hospital PG Institute and Research Centre Urun Islampur Sangli
OPD NO 5 Prasutitantra and Streerog Department LRP Ayurvedic Medical College and Hospital PG Institute and Research Centre Urun Islampur Sangli
Sangli
MAHARASHTRA
415409
India 
Phone  9766512837  
Fax    
Email  janakidinkar@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DrSachin Jagannath Patil 
Designation  Professor 
Affiliation  LRP Ayurvedic Medical College and Hospital PG Institute and Research Centre Urun Islampur Sangli  
Address  LRP Ayurvedic Medical College and Hospital PG Institute and Research Centre Urun Islampur Sangli
OPD NO 5 Prasutitantra and Streerog Department LRP Ayurvedic Medical College and Hospital PG Institute and Research Centre Urun Islampur Sangli
Sangli
MAHARASHTRA
415409
India 
Phone  9422407301  
Fax    
Email  Sachinpatil5190@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DrSachin Jagannath Patil 
Designation  Professor 
Affiliation  LRP Ayurvedic Medical College and Hospital PG Institute and Research Centre Urun Islampur Sangli  
Address  LRP Ayurvedic Medical College and Hospital PG Institute and Research Centre Urun Islampur Sangli
OPD NO 5 Prasutitantra and Streerog Department LRP Ayurvedic Medical College and Hospital PG Institute and Research Centre Urun Islampur Sangli
Sangli
MAHARASHTRA
415409
India 
Phone  9422407301  
Fax    
Email  Sachinpatil5190@gmail.com  
 
Source of Monetary or Material Support  
LRP Ayurvedic Medical College & Hospital PG Institute & Research Centre Urun Islampur Sangli 415409 Maharashtra India 
 
Primary Sponsor  
Name  Dr.Pallavi Dinkar Kamthe 
Address  LRP Ayurvedic Medical College & Hospital PG Institute & Research Centre Urun Islampur Sangli 415409 Maharashtra India 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Pallavi Dinkar Kamthe  LRP Ayurvedic Medical College And Research Institute Urun Islampur Sangli   OPD No. 5 Department Of Streerog And Prasutitantra LRP Ayurvedic Medical College And Research Institute Urun Islampur
Sangli
MAHARASHTRA 
9766512837

janakidinkar@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethical Committee LRP Ayurvedic Medical College and Hospital and PTC and RC Approved   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N72||Inflammatory disease of cervix uteri. Ayurveda Condition: YONIROGAH/YONI-VYAPADAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Panchawalkal Taila, Reference: Bhavprakash Nighantu Vatadi Varga , Route: Vaginal, Dosage Form: Taila, Dose: 10(ml), Frequency: od, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: 7 Days After Cessation Of Menses For 2 Consecutive Cycles
2Intervention ArmDrugClassical(1) Medicine Name: Erand Taila, Reference: Gad Nigrah 6/6/16, Route: Vaginal, Dosage Form: Taila, Dose: 10(ml), Frequency: od, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: 7 Days After Cessation Of Menses For 2 Consecutive Cycles
 
Inclusion Criteria  
Age From  21.00 Year(s)
Age To  50.00 Year(s)
Gender  Female 
Details  1.Only Married women in between Age group of 21-50 yrs.
2. Patient having specific symptoms of chronic pelvic inflammatory disease like
chronic pain in abdomen, previous history of acute pelvic inflammatory disease
malaise associated with lower abdominal pain and tenderness. 
 
ExclusionCriteria 
Details  1.Patients having Malignant or Benign tumor, Polyp, Fibroid, Endometriosis,
Tubo-Ovarian Mass, Adenomyosis etc.
2. Pregnant women
3.Unmarried women
4.Known case of Diabetes mellitus,HTN ,Asthma
5. Patients with pelvic inflammatory disease when seen associated with prolapsed
uterus.
6 Known case of HIV ,VDRL. 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Decrease In Sign And Symptom Of Yonidaha,Yonigat Strav,Katishoola,Ruja  7 Days 
 
Secondary Outcome  
Outcome  TimePoints 
Significant Decrease In Sign And Symptom Of Yonidaha,Yonigat Strav,Katishool,Ruja  2 Month 
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   09/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Paripluta yonivyapad has been chosen for the present study which is seen in married women of reproductive age (21-50yrs). Need has always been felt to develop certain ayurvedic treatment modalities for the management of Paripluta Yonivyapad (Chronic Pelvic inflammatory Disease) which could be safe, effective, readily available, cost effective, without any side effects in comparison to the therapeutic procedures of different systems of medicine. Ayurveda has holistic approach towards the treatment of Paripluta Yonivyapad with their backgrounds an effort is made to evaluate the efficacy of Erand taila yoni pichu in series of patients suffering from Paripluta Yonivyapad (Chronic Pelvic inflammatory Disease). The Erand taila is having properties as vata kapha shamak,Madhur vipak,kashay rasa because of these properties it help to overcome the symptoms of Paripluta Yonivyapad by increasing local immunity and prevent recurrence of symptoms in patients 
Close